Treatment of femoropopliteal arterial lesions with excimer laser atherectomy and drug-coated balloon

> 0.05).ConclusionsELA + DCB significantly improved the 1-year freedom from target lesion revascularization rate and stage 1 patency rate with no significant increase in complications or adverse events.